About the Company

We strive to be the future

Our Mission

Our mission is to help patients suffering from chronic pain in muscles and joints by increasing the patient quality of life

  • 400.000 treatment dependant patients

    In Denmark there are more than one million patients suffering from chronic pain in muscles and joints. Of this 1 million, 400 thousand is treatment dependant patients, and this has a huge impact on our society both social and economically.

  • It is estimated that 20-40% of the global population will develop chronic pain in their lifetime, which will affect the quality of life for these individuals. Only two percent of patients suffering from musculoskeletal chronic pain, receive specialized treatment, which underlines the need for a new approach. Therefore we strive to increase the patient's quality of life.

Our History

The idea derived from aalborg universitet, where they have been researching "how to measure pain" for many years

  • AUGUST 2019

    We started our entrepreneurial adventure on Innovative Growth. A startup program for entrepreneurs in Aalborg.

  • December 2019

    We received a Life Science Grant of DKK 25.000,- from Mikrolegat and Bristol-Myers Squibb.

  • February 2020

    We completed all 3 phases of the Innovative Growth program and received a grant of DKK 100.000,- for counselling.

  • SEPTEMBER 2020

    From September and a year onwards we are funded by Innovationsfonden, Denmark. We are participation in their prestigious Innofounder Gradute Program.

Meet our team

Tor Duerlund Emanuelsen
CEO and Co-Founder
Morten Kirkegaard

CSO and Co-Founder

Mathis Rosenberg Sørensen
COO and Co-Founder
REDO - Neurosystems ApS
Fredrik Bajers Vej 300, 9220 Aalborg
22 15 59 17 / 20 46 89 32
CVR: 41663685
If you want to know more about our treatment or have any questions, feel free to contact us